Endoscopic Thoracic Sympathotomy for Primary Hyperhidrosis: Predictors of Outcome Over a 10-Year Period

Endoscopic Thoracic Sympathotomy for Primary Hyperhidrosis: Predictors of Outcome Over a 10-Year Period Publisher Pubmed

Toolabi K^{1, 2} ; Parsaei R^{1, 2} ; Farid R³ ; Zamanian A²

Show Affiliations

1. Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran
2. Department of Surgery, Erfan Hospital, Tehran, Iran
3. Yafte Danesh Institute, Tehran, Iran

Source: Surgical Endoscopy Published:2022

Abstract

Background: Endoscopic thoracic sympathectomy/sympathotomy is gold standard of treatment for primary hyperhidrosis. Compensatory hyperhidrosis following surgery and partial response to surgery in some patients can significantly affect surgery outcome and patient satisfaction. In this study we investigated predictors of success rate, side effects, and satisfaction of our patients following ETS over a 10-year period. Methods: We retrospectively reviewed result of 200 Endoscopic thoracic sympathotomy surgeries that was performed in a single center to treat craniofacial, palmar, or axillary primary hyperhidrosis over a 10-year period. Patients were asked to report success of surgery to resolve their primary hyperhidrosis, development of compensatory hyperhidrosis, its severity, and their overall satisfaction with surgery. Results: Palmar hyperhidrosis was resolved in 167 (94%) patients. Craniofacial hyperhidrosis was resolved in 66 (84%) patients. Axillary hyperhidrosis was resolved in 68 (50%) patients. Compensatory hyperhidrosis developed in 176 (88%) patients. 44 (22%) patients had mild CHH, 79 (40%) patients developed moderate CHH, and 52 (26%) patients experienced severe CHH. A total of 173 (87%) patients were satisfied with surgery. 19 (9%) patients were not satisfied with ETS and 8 (4%) patients regretted ETS. Lower body mass index and grade IV primary hyperhidrosis were found to be independent predictors of patient satisfaction. Pure axillary primary hyperhidrosis was a negative predictor of patient satisfaction. Conclusion: Best results of ETS are achieved in patients with grade IV PHH and lower body mass indexes. Outcome of ETS for treating axillary PHH is not favorable. Graphic abstract: [Figure not available: see fulltext.] © 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Style	Citing Format
MLA	Toolabi K, et al.. "Endoscopic Thoracic Sympathotomy for Primary Hyperhidrosis: Predictors of Outcome Over a 10-Year Period." Surgical Endoscopy, vol. 36, no. 5, 2022, pp. 3585-3591.
APA	Toolabi K, Parsaei R, Farid R, Zamanian A (2022). Endoscopic Thoracic Sympathotomy for Primary Hyperhidrosis: Predictors of Outcome Over a 10-Year Period. Surgical Endoscopy, 36(5), 3585-3591.
Chicago	Toolabi K, Parsaei R, Farid R, Zamanian A. "Endoscopic Thoracic Sympathotomy for Primary Hyperhidrosis: Predictors of Outcome Over a 10-Year Period." Surgical Endoscopy 36, no. 5 (2022): 3585-3591.
Harvard	Toolabi K et al. (2022) 'Endoscopic Thoracic Sympathotomy for Primary Hyperhidrosis: Predictors of Outcome Over a 10-Year Period', Surgical Endoscopy, 36(5), pp. 3585-3591.
Vancouver	Toolabi K, Parsaei R, Farid R, Zamanian A. Endoscopic Thoracic Sympathotomy for Primary Hyperhidrosis: Predictors of Outcome Over a 10-Year Period. Surgical Endoscopy. 2022;36(5):3585-3591.
BibTex	@article{ author = {Toolabi K and Parsaei R and Farid R and Zamanian A}, title = {Endoscopic Thoracic Sympathotomy for Primary Hyperhidrosis: Predictors of Outcome Over a 10-Year Period}, journal = {Surgical Endoscopy}, volume = {36}, number = {5}, pages = {3585-3591}, year = {2022} }
RIS	TY - JOUR AU - Toolabi K AU - Parsaei R AU - Farid R AU - Zamanian A TI - Endoscopic Thoracic Sympathotomy for Primary Hyperhidrosis: Predictors of Outcome Over a 10-Year Period JO - Surgical Endoscopy VL - 36 IS - 5 SP - 3585 EP - 3591 PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract